CL2004000898A1 - Compuestos derivados de triazolalquilfenilamina o triazolalquilfenilamida sustituidos por oxazol y sus sales farmaceuticamente aceptables; proceso de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento del cancer. - Google Patents
Compuestos derivados de triazolalquilfenilamina o triazolalquilfenilamida sustituidos por oxazol y sus sales farmaceuticamente aceptables; proceso de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento del cancer.Info
- Publication number
- CL2004000898A1 CL2004000898A1 CL200400898A CL2004000898A CL2004000898A1 CL 2004000898 A1 CL2004000898 A1 CL 2004000898A1 CL 200400898 A CL200400898 A CL 200400898A CL 2004000898 A CL2004000898 A CL 2004000898A CL 2004000898 A1 CL2004000898 A1 CL 2004000898A1
- Authority
- CL
- Chile
- Prior art keywords
- cancer
- pharmaceutically acceptable
- triazolalquilfenilamina
- triazolalquilfenilamida
- oxazol
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title abstract 4
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 201000011510 cancer Diseases 0.000 title abstract 2
- 238000002360 preparation method Methods 0.000 title abstract 2
- ZCQWOFVYLHDMMC-UHFFFAOYSA-N Oxazole Chemical compound C1=COC=N1 ZCQWOFVYLHDMMC-UHFFFAOYSA-N 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003839 salts Chemical class 0.000 title 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
OBJETIVOS DE LA PRESENTE INVENCION SON LOS COMPUESTOS DE FORMULA (I) SUS SALES FARMACEUTICAMENTE ACEPTABLES, ENANTIOMERICAS, DIASTEREOISOMEROS, Y RACEMATOS, LA PREPARACION DE LOS COMPUESTOS ANTERIORMENTE MENCIONADOS, MEDICAMENTOS QUE LOS CONTIENEN Y SU FABRICACION, ASI COMO EL USO DE LOS COMPUESTOS ANTERIORMENTE MENCIONADOS, EN EL CONTROL O LA PREVENCION DE ENFERMEDADES TALES COMO CANCER.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03009908 | 2003-04-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2004000898A1 true CL2004000898A1 (es) | 2005-03-04 |
Family
ID=33395779
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL200400898A CL2004000898A1 (es) | 2003-04-30 | 2004-04-28 | Compuestos derivados de triazolalquilfenilamina o triazolalquilfenilamida sustituidos por oxazol y sus sales farmaceuticamente aceptables; proceso de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento del cancer. |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US7205326B2 (es) |
| EP (1) | EP1622896B1 (es) |
| JP (1) | JP2006515347A (es) |
| KR (1) | KR100763293B1 (es) |
| CN (1) | CN100345845C (es) |
| AR (1) | AR044098A1 (es) |
| AT (1) | ATE366252T1 (es) |
| AU (1) | AU2004234060A1 (es) |
| BR (1) | BRPI0409951A (es) |
| CA (1) | CA2522809A1 (es) |
| CL (1) | CL2004000898A1 (es) |
| CO (1) | CO5640050A2 (es) |
| DE (1) | DE602004007374T2 (es) |
| ES (1) | ES2290701T3 (es) |
| MX (1) | MXPA05011671A (es) |
| NO (1) | NO20054495L (es) |
| RU (1) | RU2005137033A (es) |
| TW (1) | TW200423931A (es) |
| WO (1) | WO2004096796A1 (es) |
| ZA (1) | ZA200508694B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW200612914A (en) * | 2004-03-05 | 2006-05-01 | Hoffmann La Roche | Novel oxidized thioether derivatives, their manufacture and use as pharmaceutical agents |
| FR2876692B1 (fr) | 2004-10-19 | 2007-02-23 | Sanofi Aventis Sa | Derives de 2-amido-4-phenylthiazole, leur preparation et leur application en therapeutique |
| US20060116407A1 (en) * | 2004-11-22 | 2006-06-01 | Birgit Bossenmaier | Amide derivatives |
| CA2616075A1 (en) * | 2005-08-08 | 2007-02-15 | Hans-Willi Krell | Pyrazole derivatives, their manufacture and their use as pharmaceutical agents |
| CN112920133B (zh) * | 2021-01-29 | 2022-09-16 | 中国医科大学 | (e)-4-甲基-2-(4-(三氟甲基)苯乙烯基)噁唑类化合物及其制备方法与用途 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2260999C (en) * | 1996-07-19 | 2006-07-11 | Takeda Chemical Industries, Ltd. | Heterocyclic compounds, their production and use in tyrosine kinase inhibition |
| PE20011178A1 (es) | 2000-04-07 | 2001-11-19 | Takeda Chemical Industries Ltd | Compuestos heterociclicos y su produccion |
-
2004
- 2004-04-26 TW TW093111557A patent/TW200423931A/zh unknown
- 2004-04-26 AR ARP040101415A patent/AR044098A1/es unknown
- 2004-04-28 CL CL200400898A patent/CL2004000898A1/es unknown
- 2004-04-28 US US10/833,721 patent/US7205326B2/en not_active Expired - Fee Related
- 2004-04-29 JP JP2006500101A patent/JP2006515347A/ja active Pending
- 2004-04-29 AT AT04730211T patent/ATE366252T1/de not_active IP Right Cessation
- 2004-04-29 ES ES04730211T patent/ES2290701T3/es not_active Expired - Lifetime
- 2004-04-29 KR KR1020057020486A patent/KR100763293B1/ko not_active Expired - Fee Related
- 2004-04-29 MX MXPA05011671A patent/MXPA05011671A/es active IP Right Grant
- 2004-04-29 CN CNB2004800116553A patent/CN100345845C/zh not_active Expired - Fee Related
- 2004-04-29 WO PCT/EP2004/004520 patent/WO2004096796A1/en not_active Ceased
- 2004-04-29 AU AU2004234060A patent/AU2004234060A1/en not_active Abandoned
- 2004-04-29 BR BRPI0409951-6A patent/BRPI0409951A/pt not_active IP Right Cessation
- 2004-04-29 EP EP04730211A patent/EP1622896B1/en not_active Expired - Lifetime
- 2004-04-29 DE DE602004007374T patent/DE602004007374T2/de not_active Expired - Fee Related
- 2004-04-29 RU RU2005137033/04A patent/RU2005137033A/ru not_active Application Discontinuation
- 2004-04-29 CA CA002522809A patent/CA2522809A1/en not_active Abandoned
-
2005
- 2005-09-28 NO NO20054495A patent/NO20054495L/no not_active Application Discontinuation
- 2005-10-26 ZA ZA200508694A patent/ZA200508694B/en unknown
- 2005-10-26 CO CO05109227A patent/CO5640050A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1622896B1 (en) | 2007-07-04 |
| CA2522809A1 (en) | 2004-11-11 |
| KR20060006070A (ko) | 2006-01-18 |
| BRPI0409951A (pt) | 2006-04-25 |
| CN100345845C (zh) | 2007-10-31 |
| NO20054495L (no) | 2005-11-23 |
| AR044098A1 (es) | 2005-08-24 |
| MXPA05011671A (es) | 2005-12-15 |
| WO2004096796A1 (en) | 2004-11-11 |
| DE602004007374D1 (de) | 2007-08-16 |
| NO20054495D0 (no) | 2005-09-28 |
| EP1622896A1 (en) | 2006-02-08 |
| CN1780830A (zh) | 2006-05-31 |
| JP2006515347A (ja) | 2006-05-25 |
| ATE366252T1 (de) | 2007-07-15 |
| ZA200508694B (en) | 2007-06-27 |
| US7205326B2 (en) | 2007-04-17 |
| DE602004007374T2 (de) | 2008-03-20 |
| RU2005137033A (ru) | 2006-06-27 |
| CO5640050A2 (es) | 2006-05-31 |
| AU2004234060A1 (en) | 2004-11-11 |
| KR100763293B1 (ko) | 2007-10-04 |
| US20040254217A1 (en) | 2004-12-16 |
| TW200423931A (en) | 2004-11-16 |
| ES2290701T3 (es) | 2008-02-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR063628A1 (es) | Compuestos de piridinona utiles para el tratamiento de cancer | |
| CL2004000732A1 (es) | Compuestos derivados de oximas sustituidas y sus sales farmaceuticamente aceptables; procedimiento de preparacion de dichos compuestos; composicion farmaceutica que los contiene; y uso de los compuestos para el tratamiento del cancer. | |
| BRPI0720551A2 (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, e, uso do mesmo, método para o tratamento de câncer, processos para a preparação de uma composição farmacêutica e de um composto ou de um sal farmaceuticamente aceitável do mesmo | |
| UY28691A1 (es) | Derivados de difenilazetidona | |
| ECSP109934A (es) | Compuesto - 946 | |
| EP2400847A4 (en) | SPECIFIC DIARYLHYDANTOIN AND DIARYLTHIOHYDANTOINE COMPOUNDS | |
| ECSP066302A (es) | Omega-carboxiaril-difenil-urea sustituida con flúor para el tratamiento y la prevención de enfermedades y afecciones | |
| UY28333A1 (es) | Inhibidores de caspasa y sus usos. | |
| CR8919A (es) | Analogos de tetrapeptidos | |
| UY27882A1 (es) | Compuestos quimicos | |
| ECSP078052A (es) | Nuevos derivados de la 2-azetidinona como inhibidores de la absorción del colesterol para el tratamiento de condiciones hiperlipidémicas | |
| NI201100076A (es) | Péptidos antivirales terapéuticos. | |
| DK1519724T3 (da) | Fredericamycin-derivater som lægemidler til behandling af tumorer | |
| UY31384A1 (es) | Novedosos compuestos heterociclicos para la inhibicion de la proteina quinasa b | |
| ECSP078051A (es) | Nuevos derivados de la 2-azetidinona como inhibidores de la absorción del colesterol para el tratamiento de condiciones hiperlipidémicas | |
| MX2022004451A (es) | Heteroaril-bifenil-amidas para el tratamiento de enfermedades relacionadas con el ligando pd-l1. | |
| ECSP045353A (es) | Derivados de benzoxazinona, su preparación y aplicación como medicamentos | |
| CY1111977T1 (el) | Παραγωγα πιπεριδιν-4-υλ-πυριδαζιν-3-υλαμινης ως ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2 | |
| UY28695A1 (es) | Derivados de difenilazetidona | |
| UY30282A1 (es) | Compuestos quimicos | |
| UY30723A1 (es) | Compuestos de biciclocarboxiamida sustituidos | |
| CR9223A (es) | 18-metil-19-nor-17-pregn-4-en-21, 17-carbolactonas,asi como preparaciones farmaceuticas que las contienen | |
| CR10304A (es) | Compuestos de tetrahidropiridotienopirimidina y procedimientos de uso de los mismos | |
| AR053162A1 (es) | Compuesto 5 - oxo - pirrolidin sustituido, composicion farmaceutica que lo comprende y su uso para preparar un medicamento para el tratamiento del glaucoma. | |
| CY1113759T1 (el) | Ταχεως διασπομενοι ανταγωνιστες υποδοχεα ντοπαμινης 2 |